Treatment Strategies for Hematocrit Control in PV

Insights from 2023 ASH Annual Meeting

A. Zhou

MZL: Current Management and Emerging Therapeutics

University of Miami Sylvester Comprehensive Cancer Center

I. Lossos

Pirtobrutinib in R/R B-Cell Malignancies: Newest Data From the BRUIN…

Fox Chase Cancer Center

S. Nakhoda

Caring for Patients With Lymphoma: Using Guidelines to Improve Quali…

Yale Cancer Center

S. Huntington, E. Winer

Update on Cellular Therapy in Lymphoma

Total Health

B. Randolph

Safety Profile of Ruxolitinib in Patients With MF

Icahn School of Medicine at Mount Sinai

D. Tremblay

Prevalence and Prediction of Ruxolitinib Treatment Emergent Thromboc…

Insights from 2023 ASH Annual Meeting

D. Tremblay

The Latest Data on New Therapies in FL and MZL

Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

J. Carter

Treatment-Related Quality of Life in MF

Winship Cancer Institute - Emory University

A. Hunter

Diagnosis and Goals of Therapy in PV

Northwestern Medicine Oncology and Hematology

B. Stein

MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…

ASH 2022 Conference Coverage

M. McMullin

SOHO Italy 2023: How I Manage Follicular, Marginal Zone and Mantle C…

5th SOHO Italy Annual Conference

S. Luminari

SOHO 2023 Next Questions: Indolent B-Cell Lymphoma

SOHO 2023 Eleventh Annual Meeting

L. Nastoupil

ASH 2023 Insights: "Impact of Large Cells and Ki-67% on Outcomes in …

Insights from 2023 ASH Annual Meeting

N. Epperla

Using Cytoreductive Therapy to Prevent Cardiovascular Events in Pati…

Monia Marchetti

A Clinical Case of Extranodal MZL of the Palatum Durum After CLL/SLL…

XV Eurasian Hematology-Oncology Congress - EHOC 2024

N. Ridova

Lymphoma Case Discussion: MZL Mimicking Crohn's Disease

XV Eurasian Hematology-Oncology Congress - EHOC 2024

N. Taser Kanat

ASCO® 2023 Insights: "BELLWAVE-003 - A Phase 2 Dose Escalation, Conf…

Insights from 2023 ASCO® Annual Meeting

G. Perini

SOHO Turkey 2023: Marginal Zone Lymphoma & Mantle Cell Lymphoma

SOHO Turkey 2023

O. Hermine

ASH 2023 Insights: "Ilyad Trial - Vitamin D Intervention in Patients…

ecancer

J. Friedberg